Brain monitoring co takes $3.5m in series B
This article was originally published in Clinica
Orasi Medical, a spin-out from the University of Minnesota, has raised $3.5m in series B financing. The funds, which came from un-named investors, will enable the firm to expand the development of its brain function monitoring technology into the pharmaceutical and clinical markets. Pharmaceutical companies will be able to use the test, which Orasi describes as a "quick and patient-friendly" way to monitor electrical brain activity, to assess the effects of drugs for treating neurological disorders.